Deciphering the Code: Stem Cell-Immune Function and Cardiac Regeneration
- PMID: 33800252
- PMCID: PMC8001404
- DOI: 10.3390/cells10030592
Deciphering the Code: Stem Cell-Immune Function and Cardiac Regeneration
Abstract
The development of stem-cell-based and regenerative therapies for cardiovascular and other diseases has faced an unexpected roadblock in clinical translation [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Steinhoff G., Nesteruk J., Wolfien M., Kundt G., Börgermann J., David R., Garbade J., Große J., Haverich A., Hennig H., et al. Cardiac function improvement and bone marrow response—Outcome analysis of the randomized PERFECT phase III clinical trial of intramyocardial CD133+ Application after myocardial infarction. EBioMedicine. 2017;22:208–224. doi: 10.1016/j.ebiom.2017.07.022. - DOI - PMC - PubMed
-
- Wolfien M., Klatt D., Salybekov A.A., Ii M., Komatsu-Horii M., Gaebel R., Philippou-Massier J., Schrinner E., Akimaru H., Akimaru E., et al. Hematopoietic stem-cell senescence and myocardial repair—Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3. EBioMedicine. 2020;57:102862. doi: 10.1016/j.ebiom.2020.102862. - DOI - PMC - PubMed
-
- Faulkner A., Dang Z., Avolio E., Thomas A.C., Batstone T., Lloyd G.R., Weber R.J., Najdekr L., Jankevics A., Dunn W.B., et al. Multi-omics analysis of diabetic heart disease in the db/db model reveals potential targets for treatment by a longevity-associated gene. Cells. 2020;9:1283. doi: 10.3390/cells9051283. - DOI - PMC - PubMed